CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

13 hedge funds and large institutions have $714K invested in Cyclacel Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 10 reducing their positions, and 16 closing their positions.

Holders
13
Holders Change
-13
Holders Change %
-50%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
10
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AIM
1
Acrospire Investment Management
Illinois
$29K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$380K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$224K
3
SM
3
Sabby Management
Florida
$0
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$70K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
KF
26
Krilogy Financial
Missouri
$0 50 -550 -92%
Citigroup
27
Citigroup
New York
– – -30 Closed
Deutsche Bank
28
Deutsche Bank
Germany
$0 3 +3 New
IA
29
IFP Advisors
Florida
$0 41 +41 New
1
2